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Currently, the biotechnologies, especially those based on molecular information 
and genomics, allied to the latest microelectronics developments, appear to be a key 
issue for economic development. They present decreasing costs; their offer seems to be 
unlimited even facing a growing demand; they allow to diversify the production 
structure creating new goods and services; they are pervasive and dynamic enough to 
transform rapidly a huge variety and diversity of productive activities; and thus, 
represent one of the fundamental basis of a new pattern of innovation, both technical 
and organizational, at worldwide scale1. 
In this way, the biotechnologies involve challenges not only to the dynamism of 
developed world economies but also and mainly to developing countries, as Brazil, 
where there is an urgent need for appropriating existing technologies and accumulating 
endogenous capacity to the development of local agricultural and industrial productive 
structure. 
However, in general, the proper identification of advancements on Science, 
Technology and Innovation faces methodologies barriers difficult to overcome. 
Generally, the conceptual framework for data systematization, which is supposed to be 
the basis to identification and to measure these advancements, seems to be not suitable 
for this purpose. 
Some of the main database are organized by economic criteria ((International 
Standard Industrial Classification of All Economic Activities - ISIC) or by knowledge 
areas such (biology, health, engineering, physics, chemistry, technology of information 
etc) which are not capable to deal with new biotechnology due its characteristics of 
pervasiveness, multidisciplinary and transversal approach across all this different 
economic and knowledge areas.  
In this context, the paper aims to systemize some Indicators of Science, 
Technology and Innovation suitable to report the recent advancement of Brazilian 
Biotech sector2.    
How could this be done? Due the existent controversies about this technologies 
field delimitation it is very important that a previous effort to properly define the 
meaning of biotechnology. Thus, for the purpose of this paper the main reference used 
is the Organization for Economic Co-operation and Development (OECD) definition: 
"the application of science and technology to living organisms, as well as parts, 
products and models thereof, to alter living or nonliving materials for the production of 
knowledge, goods and services.”3 
So, using this definition and its translation into key terms4 and codes of 
International Patent Classification - IPC5, it was possible to access some databases 
                                                 
1 PÉREZ, Carlota. The new technologies: an integrated view. July, 1986. English version of the original 
Spanish; "Las Nuevas Tecnologías: Una Visión de Conjunto" (1986), in C. Ominami ed., La Tercera 
Revolución Industrial: Impactos Internacionales del Actual Viraje Tecnológico, Grupo Editor 
Latinoamericano, Buenos Aires, 1986, pp. 44-89 (http://www.carlotaperez.org/papers/basic-
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2 From 2000; 
3 OECD Biotechnology Statistics - 2006, p. 7; 
4 Biotechnology in Mercosul: english version of the original Biotecnología en el Mercosur: Delimitación 
del Campo de Análisis (2007) within the Project Biotech - Inventario diagnóstico de las biotecnologías 
en el MERCOSUR y comparación con las de la UE, p. 6 e 7. 
5 OECD Biotechnology Statistics - 2006, p. 44; e OECD.Compendium of patent statistics, 2007, p. 18 
(www.oecd.org). 
currently available in Brazil and other countries to create indicators to Science, 
Technology and Innovation6 as showed in the table bellow: 
 
Table 1: Science, Technology and Innovation Indicators of Brazilian Biotechnology 
Sector. 
INDICATOR DATABASE7 
1. Post graduation in biotechnology: quantity 
and areas of offered courses.  
DataCapes (www.capes.gov.br) 
2. Number of  de researchers, PhDs and 
research groups in biotechnology 
Plataforma Lattes  
(www.lattes.cnpq.br) 
3. Formal employment  in biotechnology Relação Anual de Informações Sociais 
(www.mtb.gov.br) 
4. Number of publications by Brazilian 
institutions cited in the Science Citation Index -
SCI; Number of publications by Brazilian 
institutions with international cooperation in the 
SCI; Number of publications of Brazilian 
institutions with international cooperation cited 
in the SCI by country. 
SCI (www.thomsonreuters.com) e 
Projecto Biotech – Inventario 
diagnóstico de las biotecnologías en el 
MERCOSUR y comparación con las 
de la UE 
(www.mincyt.gov.ar/web_biotech)  
5. Number of patents on Biotechnology filed by 
citizens and foreign at Brazilian Agency for 
Industrial Property 
INPI (www.inpi.gov.br)  
6. Number of patents on Biotechnology filed by 
Brazilian citizens at the United States 
Trademark Patent Office - USPTO 
USPTO  
(www.uspto.gov) 
7. Number of releases to market of Genetically 
Modified Organism (GMO) 
National Committee for Biosafety 
Issues National Committee for 
Biosafety Issues – CTNBio 
(www.ctnbio.gov.br.) 
8. Cultivation area of GMO Crops International Service for the 
Acquisition of Agri-biotech 
Applications ISAAA (www.isaaa.org) 
9. Brazilian Biotech firms profile  Biominas Foundation  
(www.biominas.org.br) 
 
Besides, OECD also set up a definition to biotech firms: “the definition of a core 
biotechnology firm varies, but in most countries a core biotechnology firm must perform 
R&D in biotechnology and biotechnology must be its principal activity”.8  
Assuming this definition it is also possible to identify and to characterize the 
Brazilian biotech firms based on the survey done by BIOMINAS Foundation.9 .  
                                                 
6 Others important references are available at: Frascati (OECD, 2002) and Oslo (OECD, 1997) Manuals 
(www.oecd.org). 
7 The methodology of these different sources of date will be discussed along with the paper.  
8 OECD Biotechnology Statistics – 2006, p. 8 
A previous version of this paper was prepared by the authors. The main findings 
of this paper were: 
a) There is currently 31 post graduation programs in Biotech available in Brazil, 
most of them launched after 2000. Amongst them, 19 offer PhD and MSc 
degrees, 11 only MSc courses and 1 Professional Master Degree; 
b) Between 2000 and 2008 (April), the amount of Research Groups on 
Biotechnology rocket from 249 to 790; 
c) During the period 2003 – 2006, the number of biotech graduated employees 
presented a growing rate higher then 100% while biotech technicians presented a 
negative rate along the same period; 
d) Between 2000 and 2007, the Brazilian Publications cited in the Science Citation 
Index – SCI increased 300%. A third part of this publication is subject of 
international cooperation; 
e) During the period of 2000 and 2005, 512 patents were filed annually at Brazilian 
IP agency. In average, 93% of this patents were requested by non-residents; 
f) Regarding the International Service for the Acquisition of Agri-biotech 
Applications – ISAAA, amongst the four main producers countries (USA, 
Argentina, Brazil and Canada), Brazil presents the fastest rate of growth in the 
cultivated biotech crops area (30,4%) between 2006 - 2007; 
g) In Brazil, according to the National Committee for Biosafety Issues (CTNBio), 
only two biotech crops were allowed to be cultivated until 2006: Roundup 
Ready and Bollgard 1. Within one year this agency has added three other 
biotech crops: Libert Link, Guard and BT11; 
h) According to the BIOMINAS Foundation, in 2007 there were 71 biotech firms 
in Brazil. The increase in the number of biotech firms in this country is recent: 
51% were created after 2002 and 21% have between 5 and 10 years of operation. 
The biotech firms are clustered around Agriculture (22.5%), Imputs (21.1%), 
Animal Health (18.3%) and Human Health (16.9%). Roughly 78% of them are 
small business with less than 20 employees.  
 
Summarizing, the paper aims to discuss possible ways to fill up the current lack of 
systematized indicators for biotechnology in Brazil, bringing up lessons that could be 
used for similar initiatives in other countries.  
                                                                                                                                               
9 FUNDAÇÃO BIOMINAS. “Estudo das Empresas de Biotecnologia do Brasil” – 2007 
(www.biominas.org.br). 
